Teva wins Canadian Viagra row
This article was originally published in Scrip
Teva can now start marketing generic versions of Pfizer's erectile dysfunction drug Viagra (sildenafil) in Canada. The Supreme Court there yesterday backed Teva's challenge to the drug's patent, which was due to expire in 2014.
You may also be interested in...
The World Trade Organization is not the place to discuss pharmaceutical pricing, and strong intellectual property rights do not threaten access to medicines, according to EU and US delegations to the WTO.
Brazil’s medicines regulator, ANVISA, finally has a new set of rules for the evaluation and marketing authorization of advanced therapy medicines.